Definium Therapeutics, Inc. (DFTX) vs Heartflow, Inc. Common Stock (HTFL)

A side-by-side comparison of Definium Therapeutics, Inc. and Heartflow, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Definium Therapeutics, Inc. logo
DFTX
Definium Therapeutics, Inc.
$4.68B
$35.27HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
Heartflow, Inc. Common Stock logo
HTFL
Heartflow, Inc. Common Stock
$4.38B
$50.74HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT

Total return — DFTX vs HTFL

growth of $100 · dividends reinvested · last 1y
DFTX +267.8% (+267.8%/yr)HTFL +81.6% (+81.6%/yr)DFTX compounded faster over this window
100200300400500Start $1002026$368$182
DFTX HTFL

DFTX vs HTFL: by the numbers

  • •DFTX is the larger company ($4.68B vs $4.38B market cap).
  • •Both run net losses; DFTX's is the smaller (0.00% vs -55.82% net margin).

Metrics side by side

Valuation

MetricDFTXHTFL
P/S ratioN/A20.63
P/B ratio5.1015.64

Profitability

MetricDFTXHTFL
Gross margin0.00%80.08%
Operating margin0.00%-34.31%
Net margin0.00%-55.82%
ROE-38.51%-42.32%
ROIC-23.81%-23.69%

Growth (annualized)

MetricDFTXHTFL
Total return CAGR (5Y)1.43%N/A

Go deeper

Full DFTX analysisFull HTFL analysisInteractive comparison tool

Dig into the metrics

Definium Therapeutics ROEHeartflow, Inc. Common Stock ROEDefinium Therapeutics operating marginHeartflow, Inc. Common Stock operating marginDefinium Therapeutics revenue growthHeartflow, Inc. Common Stock revenue growthDefinium Therapeutics free cash flowHeartflow, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.